W. van Duijnhoven

Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.

P. van Damme, J. Heldens, H. van den Bosch, 2014, Vaccine.

A novel guinea pig model of Chlamydia trachomatis genital tract infection.

M. D. de Jonge, P. Nuijten, P. Verweij, 2011, Vaccine.

A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study

M. Ison, B. O'Neil, A. Torres, 2020, The Journal of infectious diseases.

Meta-analyses of the efficacy of asenapine for acute schizophrenia: comparisons with placebo and other antipsychotics.

H. Fennema, A. Szegedi, P. Verweij, 2012, The Journal of clinical psychiatry.

Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.

H. Sparr, F. Pühringer, B. Klarin, 2010, British journal of anaesthesia.

Effective Reversal of Moderate Rocuronium- or Vecuronium-induced Neuromuscular Block with Sugammadex, a Selective Relaxant Binding Agent

P. Hans, G. Cammu, M. Heeringa, 2007, Anesthesiology.

Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.

H. Schuitemaker, N. Frahm, M. McElrath, 2016, JAMA.

Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial

R. Finberg, Riin Lanno, R. Fleischhackl, 2018, The Journal of infectious diseases.